Navigation Links
Genome BC collaborates with Chile and Norway to sequence salmon genome
Date:12/7/2009

The economically important, environmentally sensitive Atlantic salmon species will have its genome fully sequenced, thanks to an international collaboration involving researchers, funding agencies and industry from Canada, Chile and Norway.

Genome BC is partnering with the Chilean Economic Development Agency, InnovaChile, Norwegian Research Council, Norwegian Fishery and Aquaculture Industry Research Fund to form the International Cooperation to Sequence the Atlantic Salmon Genome (Cooperation).

The Cooperation will invest approximately US$6 million in phase one of a multi-phased project to produce a genome sequence that identifies and maps all of the genes in the Atlantic salmon genome and can act as a reference/guide sequence for the genomes of other salmonids (e.g. Pacific salmon, rainbow trout and more distantly related fish such as smelt and pike.)

With salmonid product exports from Norway, Chile and Canada valued at US$3.4 billion, US$2.3 billion and US$0.6 billion, respectively in 2007, the sequenced genome will be an important public resource that may lead to better management of wild fish stocks, breeding selection for commercially important traits, and elements of food quality, security and traceability.

In addition, the fully annotated salmon genome will provide important clues about the impact of cultured fish escapees on wild populations, conservation of populations at risk, strategies for combating pathogens, as well as allowing for more accurate assessments of the sustainability of aquatic environments.

Dr. Ben Koop sits on the Cooperation's Executive Science Committee. "This project is an international effort to address - in a whole new way - questions that are of economic and social importance to aquaculture, conservation, and the environment," he says.

"The genomic data that we will acquire will be crucial to the development of new methods and products that will assist the world's wild fisheries and aquaculture industries," says Genome BC's Chief Scientific Officer, Dr. Pierre Meulien. "In addition, this research builds on knowledge obtained through earlier fisheries research funded by Genome BC."

Following the release of a Request for Proposals in June 2009, the Cooperation completed a rigorous international scientific peer review process and selected Beckman Coulter Genomics Inc., formerly Agencourt Bioscience and Cogenics, of Beverly, Massachusetts to fulfill the contract for phase one of the project.

Beckman Coulter Genomics, well known for their role in the sequencing of many high profile genomes, will complete phase one of the project, (worth approximately US $6 million,) by early 2011 and release the data as quickly as possible into the public domain.

"This research investment will result in an invaluable resource that can be used by any research group around the world," says Dr. Sigbjrn Lien of the Norwegian University of Life Sciences, and the Cooperation's Executive Science Committee.

Dr. Alejandro Maas of the University of Chile is also a member of the Executive Science Committee. "Through better understanding of this species, and its genome, this timely and strategic research collaboration will enable the growth and management of a global fishery," he says.


'/>"/>

Contact: Sally Greenwood
sgreenwood@genomebc.ca
604-637-4373
Genome BC
Source:Eurekalert

Related biology news :

1. Unravelling new complexity in the genome
2. Conquest of land began in shark genome
3. One species entire genome discovered inside anothers
4. Genome study shines light on genetic link to height
5. First individual genome sequence published
6. Ultraconserved elements in the genome: Are they indispensable?
7. $10 million gift to support cutting-edge epigenome center at USC
8. Fungus genome yielding answers to protect grains, people and animals
9. Which came first, the chicken genome or the egg genome?
10. Researchers expand efforts to explore functional landscape of the human genome
11. Genome update defines landscape of breast and colon cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis zum Jahr 2018 ... mehr als 50 Vertretern aus verschiedenen Branchen wurde aber klar, ... Prognose zu realisieren. ... Zu den Schwierigkeiten für Biobanking-Profis ... die Biobank, die Implementierung Zeit sparender Technologien, ein besseres ...
(Date:2/10/2017)... , Feb 10, 2017 ... new report "Personalized Medicine - Scientific and Commercial Aspects" ... ... personalized medicine. Diagnosis is integrated with therapy for selection of ... on early detection and prevention of disease in modern medicine. ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 /PRNewswire/ ... point. Driven largely by the confluence of organizations, ... users, distaste for knowledge-based systems (password and challenge ... consumer, industrial, and government systems. The market is ... been a demarcation between consumer and enterprise uses ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... 2017  In Atlanta, it seems everyone has a chance ... to create an expressive and dynamic community unlike any other. ... contribute to it. With their newest salon ... seeks to carry on that tradition with a unique, fresh ... salon is the newest of 13 nationwide locations, each ...
(Date:2/23/2017)... ... February 23, 2017 , ... David Nolte, PhD ... Reception at Purdue Research Park of West Lafayette, Indiana. , The ... outstanding contributions to, and success with, commercializing discoveries from Purdue research. “This award ...
(Date:2/23/2017)... and SAN FRANCISCO , Feb. 23, ... medicine company, and Beyond Type 1, a not-for-profit advocacy ... diabetes, today announced a grant from Beyond Type 1 ... for type 1 and other insulin-requiring diabetes.  ... developing innovative stem cell-derived cell replacement therapies with a ...
(Date:2/22/2017)... , Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. ... be presenting at the Annual Biocom Global Life Science ... 2, at 11:15 AM, at the Torrey Pines Lodge, ... to the organizers at Biocom who have chosen our ... symposium of biotechnology companies, investors, and clinical researchers," said ...
Breaking Biology Technology: